首页> 外文期刊>International Journal on Advances in ICT for Emerging Regions (ICTer) >Predicting Drug-Drug Interactions for Premarket Drug Development Process: A Network Based Approach
【24h】

Predicting Drug-Drug Interactions for Premarket Drug Development Process: A Network Based Approach

机译:预测售前药品开发过程中的药品相互作用:基于网络的方法

获取原文
       

摘要

pDrug-drug interactions (DDIs) are responsible for many serious adverse events; their detection is crucial for the safety of the patient but also it is very challenging. In recent years, several drugs have been withdrawn from the market due to interaction related Adverse Events (AEs).pThis study describes a model which can be used to predict novel DDIs based on the similarity of drug interaction candidates to drugs involved in established DDIs which can be used in a large scale to discover novel DDIs. This model is mainly based on the assumption that if drug A and drug B interact to produce a specific biological effect, then drugs similar to drug A (or drug B) are likely to interact with drug B (or drug A) to produce the same effect. We have created a drug network using the 2011 snapshot of a widely used drug safety database which utilizes 352 distinct drugs and contains 3 700 interactions. Then, it was used to develop the proposed model for predicting future DDIs. The target similarities and side effect similarities (P-score) were calculated for all selected pairs of drugs. Then, it was used to develop the proposed model for predicting future DDIs. The proposed model mainly follows two distinct approaches: ‘Which forces the preservation of existing (known) DDIs’ and ‘Without forced to preserve existing DDIs.’ Underneath each of these approaches, three different techniques: target similarity score, side effect similarity (P-score) and resulting score were used to retrieve novel DDIs.pThe proposed model was evaluated using the Drugbank 2014 snapshot as a gold standard for the same set of drugs which produce novel DDIs with an average accuracy of 95% and 92%, average AUC (Area Under the Curve) of 0.9834 and 0.8651 under each of these two approaches respectively.pThe results presented in this study demonstrate the usefulness of the proposed network based drug-drug interaction methodology as a promising approach. The method described in this article is very simple, efficient, and biologically sound.
机译:药物相互作用(DDI)是造成许多严重不良事件的原因。它们的检测对于患者的安全至关重要,但也非常具有挑战性。近年来,由于与相互作用有关的不良事件(AE),一些药物被撤出市场。>本研究描述了一种模型,该模型可根据候选药物与候选药物的相似性来预测新的DDI。已建立的DDI,可以大规模用于发现新颖的DDI。该模型主要基于以下假设:如果药物A和药物B相互作用产生特定的生物学效应,则类似于药物A(或药物B)的药物很可能与药物B(或药物A)相互作用以产生相同的生物学效应。影响。我们使用广泛使用的药物安全性数据库的2011年快照创建了一个药物网络,该数据库利用352种不同的药物并包含3700种相互作用。然后,它被用来开发用于预测未来DDI的建议模型。计算所有选定药物对的靶标相似性和副作用相似性(P评分)。然后,它被用来开发用于预测未来DDI的建议模型。提出的模型主要遵循两种不同的方法:“哪个强制保留现有(已知)DDI”和“不强制保留现有DDI”。在这些方法的每种方法下,三种不同的技术:目标相似性评分,副作用相似性(P -分数)和所得分数用于检索新的DDI。>使用Drugbank 2014快照作为黄金标准对提议的模型进行了评估,该药物是生产新DDI的同一组药物的平均准确度为95%和92% ,这两种方法各自的平均AUC(曲线下面积)分别为0.9834和0.8651。>本研究显示的结果证明了所提出的基于网络的药物相互作用方法作为一种有前途的方法是有用的。本文中描述的方法非常简单,有效并且具有生物学上的合理性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号